132 related articles for article (PubMed ID: 30664689)
1. Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.
Das S; Nair RS; Mishra R; Sondarva G; Viswakarma N; Abdelkarim H; Gaponenko V; Rana B; Rana A
Oncogene; 2019 May; 38(19):3569-3584. PubMed ID: 30664689
[TBL] [Abstract][Full Text] [Related]
2. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
Chen J; Miller EM; Gallo KA
Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
[TBL] [Abstract][Full Text] [Related]
3. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
Das S; Sondarva G; Viswakarma N; Nair RS; Osipo C; Tzivion G; Rana B; Rana A
J Biol Chem; 2015 Aug; 290(35):21705-12. PubMed ID: 26152725
[TBL] [Abstract][Full Text] [Related]
4. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3.
Singh SK; Kumar S; Viswakarma N; Principe DR; Das S; Sondarva G; Nair RS; Srivastava P; Sinha SC; Grippo PJ; Thatcher GRJ; Rana B; Rana A
Oncogene; 2021 Oct; 40(43):6153-6165. PubMed ID: 34511598
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
Hammer A; Diakonova M
BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
[TBL] [Abstract][Full Text] [Related]
6. Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity.
Kumar S; Singh SK; Viswakarma N; Sondarva G; Nair RS; Sethupathi P; Sinha SC; Emmadi R; Hoskins K; Danciu O; Thatcher GRJ; Rana B; Rana A
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7961-7970. PubMed ID: 32209667
[TBL] [Abstract][Full Text] [Related]
7. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis.
Chen J; Gallo KA
Cancer Res; 2012 Aug; 72(16):4130-40. PubMed ID: 22700880
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
[TBL] [Abstract][Full Text] [Related]
9. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
10. Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.
Mishra P; Senthivinayagam S; Rangasamy V; Sondarva G; Rana B
Mol Endocrinol; 2010 Mar; 24(3):598-607. PubMed ID: 20150185
[TBL] [Abstract][Full Text] [Related]
11. TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer.
Nair RS; Kumar S; Das S; Singh SK; Srivastava P; Sondarva G; Rao A; Sinha SC; Xiong R; Bloem L; Hoskins K; Thatcher GRJ; Rana B; Rana A
Oncogene; 2023 Mar; 42(14):1132-1143. PubMed ID: 36813855
[TBL] [Abstract][Full Text] [Related]
12. LKB1 suppresses p21-activated kinase-1 (PAK1) by phosphorylation of Thr109 in the p21-binding domain.
Deguchi A; Miyoshi H; Kojima Y; Okawa K; Aoki M; Taketo MM
J Biol Chem; 2010 Jun; 285(24):18283-90. PubMed ID: 20400510
[TBL] [Abstract][Full Text] [Related]
13. MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
Schroyer AL; Stimes NW; Abi Saab WF; Chadee DN
Oncogene; 2018 Feb; 37(8):1031-1040. PubMed ID: 29084209
[TBL] [Abstract][Full Text] [Related]
14. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.
Oladimeji P; Skerl R; Rusch C; Diakonova M
Cancer Res; 2016 May; 76(9):2600-11. PubMed ID: 26944939
[TBL] [Abstract][Full Text] [Related]
16. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.
Mishra R; Barthwal MK; Sondarva G; Rana B; Wong L; Chatterjee M; Woodgett JR; Rana A
J Biol Chem; 2007 Oct; 282(42):30393-405. PubMed ID: 17711861
[TBL] [Abstract][Full Text] [Related]
18. Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.
Rangasamy V; Mishra R; Mehrotra S; Sondarva G; Ray RS; Rao A; Chatterjee M; Rana B; Rana A
Cancer Res; 2010 Feb; 70(4):1731-40. PubMed ID: 20145118
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
Yellapu NK; Pulaganti M; Pakala SB
J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
